In corporate news,
Knight Capital Group
shares extended the prior session's gains as it popped by 5.3% following a report from
The Wall Street Journal
that the firm may sell its market-making business, the company's most profitable unit. The
reported that Knight had been approached by at least two competitors about buying the business.
shares popped 6.9%. The glass manufacturer announced expectations of stronger-than-forecast fourth-quarter LCD glass volume and full-year sales of Corning Gorilla Glass approaching $1 billion, amid stronger-than-expected retail demand for LCD televisions and other consumer electronics devices in North America and China.
shares surged 26.4% after the private-brand food products company announced that
will acquire all outstanding shares of Ralcorp for $90 a share in cash.
Ralcorp on Tuesday also revealed better-than-expected fourth-quarter earnings of 92 cents a share; analysts, on average, were expecting earnings of 87 cents a share. Revenue came in at $1.07 billion, compared with expectations of $1.1 billion. ConAgra shares tacked on 4.7%.
Green Mountain Coffee Roasters
were soaring more than 20% in extended trades after the company trounced Wall Street's expectations for its fourth-quarter results, reporting a non-GAAP profit of 64 cents a share with net sales rising 33% year-over-year to $946.7 million, well ahead of the consensus view for earnings of 48 cents a share on revenue of $902.7 milion.
The board of
Las Vegas Sands
declared a special dividend of $2.75 a share after Monday's closing bell. Shares jumped 5.3%.
, the discount retailer, will join the
, which is being acquired by
Dollar General shares finished up 0.41%.
agreed Monday to jointly purchase the assets of Archstone Enterprise LP, mainly a portfolio of apartment properties, from
Equity Residential shares gained 1.5% and AvalonBay shares rose 2.6%.
shares bumped up 6.6% after being upgraded to buy from hold at Cantor.
shares soared 136.1% after the company announced that its experimental antipsychotic treatment exhibited solid progress in a phase 3 trial in treating patients afflicted with Parkinson's disease psychosis.
-- Written by Andrea Tse and Joe Deaux in New York.
>To contact the writer of this article, click here: